BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29274627)

  • 1. Regulation of ABCG2 by nuclear factor kappa B affects the sensitivity of human lung adenocarcinoma A549 cells to arsenic trioxide.
    Jiang X; Chen C; Gu S; Zhang Z
    Environ Toxicol Pharmacol; 2018 Jan; 57():141-150. PubMed ID: 29274627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the resveratrol and arsenic trioxide combination induced apoptosis and its mechanism on lung adenocarcinoma cells].
    Gu S; Chen C; Jiang X; Zhang Z
    Wei Sheng Yan Jiu; 2016 Jan; 45(1):87-92. PubMed ID: 26987203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol synergistically triggers apoptotic cell death with arsenic trioxide via oxidative stress in human lung adenocarcinoma A549 cells.
    Gu S; Chen C; Jiang X; Zhang Z
    Biol Trace Elem Res; 2015 Feb; 163(1-2):112-23. PubMed ID: 25431299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Arsenic trioxide enhances TRAIL inducing human lung cancer cell line A549 cells apoptosis by down-regulate the expression of NF-kappaB].
    Wang JY; Zhao XQ; Wang CM; Mo BW; Jiang M; Chen F
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):834-8. PubMed ID: 23387208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular signal-regulated kinase 8-mediated NF-κB activation increases sensitivity of human lung cancer cells to arsenic trioxide.
    Wu DD; Lau ATY; Yu FY; Cai NL; Dai LJ; Ok Kim M; Jin DY; Xu YM
    Oncotarget; 2017 Jul; 8(30):49144-49155. PubMed ID: 28467781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia: studies of cytotoxicity, apoptosis and the pattern of resistance.
    Lehmann S; Bengtzen S; Paul A; Christensson B; Paul C
    Eur J Haematol; 2001 Jun; 66(6):357-64. PubMed ID: 11488934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction.
    Li H; Zhu X; Zhang Y; Xiang J; Chen H
    J Exp Clin Cancer Res; 2009 Aug; 28(1):110. PubMed ID: 19664237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells.
    Tabellini G; Cappellini A; Tazzari PL; Falà F; Billi AM; Manzoli L; Cocco L; Martelli AM
    J Cell Physiol; 2005 Feb; 202(2):623-34. PubMed ID: 15316930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling.
    Vesel M; Rapp J; Feller D; Kiss E; Jaromi L; Meggyes M; Miskei G; Duga B; Smuk G; Laszlo T; Karner I; Pongracz JE
    Respir Res; 2017 Mar; 18(1):52. PubMed ID: 28340578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydroartemisinin Sensitizes Human Lung Adenocarcinoma A549 Cells to Arsenic Trioxide via Apoptosis.
    Chen H; Gu S; Dai H; Li X; Zhang Z
    Biol Trace Elem Res; 2017 Oct; 179(2):203-212. PubMed ID: 28261759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of leukemic T-cell lines to arsenic trioxide cytotoxicity is dependent on the induction of phosphatase B220/CD45R expression at the cell surface.
    Benbijja M; Mellouk A; Bobé P
    Mol Cancer; 2014 Nov; 13():251. PubMed ID: 25410152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide and auranofin inhibit selenoprotein synthesis: implications for chemotherapy for acute promyelocytic leukaemia.
    Talbot S; Nelson R; Self WT
    Br J Pharmacol; 2008 Jul; 154(5):940-8. PubMed ID: 18587442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle arrest and apoptotic cell death in cultured human gastric carcinoma cells mediated by arsenic trioxide.
    Shao QS; Ye ZY; Ling ZQ; Ke JJ
    World J Gastroenterol; 2005 Jun; 11(22):3451-6. PubMed ID: 15948253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatment.
    Gatti L; Cossa G; Tinelli S; Carenini N; Arrighetti N; Pennati M; Cominetti D; De Cesare M; Zunino F; Zaffaroni N; Perego P
    J Pharmacol Exp Ther; 2014 Mar; 348(3):360-71. PubMed ID: 24345465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
    Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
    Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Toxicity of arsenic trioxide to human lung adenocarcinoma cell line SPCA1 and its mechanism].
    Wei L; Wang XW; Zuo WS
    Ai Zheng; 2004 Dec; 23(12):1633-8. PubMed ID: 15601551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the mechanism involved in the As2O3-regulated decrease in MDR1 expression in leukemia cells.
    Gao F; Liu J; Dong WW; Wang W; Wang Y; Cai D; Zheng Z; Sun K
    Oncol Rep; 2014 Feb; 31(2):926-32. PubMed ID: 24337533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells.
    Gu S; Chen C; Jiang X; Zhang Z
    Chem Biol Interact; 2016 Feb; 245():100-9. PubMed ID: 26772155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional expression and characterization in Xenopus laevis oocytes of the ABCG2 transporter derived from A549 human lung adenocarcinoma cells.
    Lee DG; Cho HJ; Yi H; Cho SM; Jo K; Park JA; Lee BH; Hwang SH; Jeong SM; Nah SY; Shin HC
    Oncol Rep; 2012 Feb; 27(2):499-503. PubMed ID: 21971989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine.
    Maeda H; Hori S; Ohizumi H; Segawa T; Kakehi Y; Ogawa O; Kakizuka A
    Cell Death Differ; 2004 Jul; 11(7):737-46. PubMed ID: 15002036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.